 | • レポートコード：MRC2-11QY08831 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はペプチドのグローバル市場について調査・分析したレポートです。種類別（インスリン、テリパラチド、リラグルチド、リュープロリド）市場規模、用途別（糖尿病、感染症、がん、骨粗鬆症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ペプチドの競争状況、市場シェア ・世界のペプチド市場：種類別市場規模 2015年-2020年（インスリン、テリパラチド、リラグルチド、リュープロリド） ・世界のペプチド市場：種類別市場規模予測 2021年-2026年（インスリン、テリパラチド、リラグルチド、リュープロリド） ・世界のペプチド市場：用途別市場規模 2015年-2020年（糖尿病、感染症、がん、骨粗鬆症） ・世界のペプチド市場：用途別市場規模予測 2021年-2026年（糖尿病、感染症、がん、骨粗鬆症） ・北米のペプチド市場分析：米国、カナダ ・ヨーロッパのペプチド市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのペプチド市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のペプチド市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのペプチド市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Cipla Ltd.、Emcure Pharmaceuticals Pvt. Ltd.、Gland Pharma Limited、Troikaa Pharmaceuticals Ltd.、Biological E Limited、Bharat Biotech、Samarth Life Sciences Pvt. Ltd.、VHB Life Sciences Limited、Celon Laboratories Pvt. Ltd.、United Biotech (P) Limited ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Peptides Market
The global Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Peptides Scope and Market Size
Peptides market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Peptides market is segmented into
Insulin
Teriparatide
Liraglutide
Leuprolide
Segment by Application, the Peptides market is segmented into
Diabetes
Infectious Diseases
Cancer
Osteoporosis
Regional and Country-level Analysis
The Peptides market is analysed and market size information is provided by regions (countries).
The key regions covered in the Peptides market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Peptides Market Share Analysis
Peptides market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Peptides business, the date to enter into the Peptides market, Peptides product introduction, recent developments, etc.
The major vendors covered:
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech (P) Limited
1 Study Coverage
1.1 Peptides Product Introduction
1.2 Market Segments
1.3 Key Peptides Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Peptides Market Size Growth Rate by Type
1.4.2 Insulin
1.4.3 Teriparatide
1.4.4 Liraglutide
1.4.5 Leuprolide
1.5 Market by Application
1.5.1 Global Peptides Market Size Growth Rate by Application
1.5.2 Diabetes
1.5.3 Infectious Diseases
1.5.4 Cancer
1.5.5 Osteoporosis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Peptides Market Size, Estimates and Forecasts
2.1.1 Global Peptides Revenue 2015-2026
2.1.2 Global Peptides Sales 2015-2026
2.2 Global Peptides, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Peptides Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Peptides Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Peptides Competitor Landscape by Players
3.1 Peptides Sales by Manufacturers
3.1.1 Peptides Sales by Manufacturers (2015-2020)
3.1.2 Peptides Sales Market Share by Manufacturers (2015-2020)
3.2 Peptides Revenue by Manufacturers
3.2.1 Peptides Revenue by Manufacturers (2015-2020)
3.2.2 Peptides Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Peptides Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Peptides Revenue in 2019
3.2.5 Global Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Peptides Price by Manufacturers
3.4 Peptides Manufacturing Base Distribution, Product Types
3.4.1 Peptides Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Peptides Product Type
3.4.3 Date of International Manufacturers Enter into Peptides Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Peptides Market Size by Type (2015-2020)
4.1.1 Global Peptides Sales by Type (2015-2020)
4.1.2 Global Peptides Revenue by Type (2015-2020)
4.1.3 Peptides Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Peptides Market Size Forecast by Type (2021-2026)
4.2.1 Global Peptides Sales Forecast by Type (2021-2026)
4.2.2 Global Peptides Revenue Forecast by Type (2021-2026)
4.2.3 Peptides Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Peptides Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Peptides Market Size by Application (2015-2020)
5.1.1 Global Peptides Sales by Application (2015-2020)
5.1.2 Global Peptides Revenue by Application (2015-2020)
5.1.3 Peptides Price by Application (2015-2020)
5.2 Peptides Market Size Forecast by Application (2021-2026)
5.2.1 Global Peptides Sales Forecast by Application (2021-2026)
5.2.2 Global Peptides Revenue Forecast by Application (2021-2026)
5.2.3 Global Peptides Price Forecast by Application (2021-2026)
6 North America
6.1 North America Peptides by Country
6.1.1 North America Peptides Sales by Country
6.1.2 North America Peptides Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Peptides Market Facts & Figures by Type
6.3 North America Peptides Market Facts & Figures by Application
7 Europe
7.1 Europe Peptides by Country
7.1.1 Europe Peptides Sales by Country
7.1.2 Europe Peptides Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Peptides Market Facts & Figures by Type
7.3 Europe Peptides Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Peptides by Region
8.1.1 Asia Pacific Peptides Sales by Region
8.1.2 Asia Pacific Peptides Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Peptides Market Facts & Figures by Type
8.3 Asia Pacific Peptides Market Facts & Figures by Application
9 Latin America
9.1 Latin America Peptides by Country
9.1.1 Latin America Peptides Sales by Country
9.1.2 Latin America Peptides Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Peptides Market Facts & Figures by Type
9.3 Central & South America Peptides Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Peptides by Country
10.1.1 Middle East and Africa Peptides Sales by Country
10.1.2 Middle East and Africa Peptides Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Peptides Market Facts & Figures by Type
10.3 Middle East and Africa Peptides Market Facts & Figures by Application
11 Company Profiles
11.1 Cipla Ltd.
11.1.1 Cipla Ltd. Corporation Information
11.1.2 Cipla Ltd. Description and Business Overview
11.1.3 Cipla Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cipla Ltd. Peptides Products Offered
11.1.5 Cipla Ltd. Related Developments
11.2 Emcure Pharmaceuticals Pvt. Ltd.
11.2.1 Emcure Pharmaceuticals Pvt. Ltd. Corporation Information
11.2.2 Emcure Pharmaceuticals Pvt. Ltd. Description and Business Overview
11.2.3 Emcure Pharmaceuticals Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Emcure Pharmaceuticals Pvt. Ltd. Peptides Products Offered
11.2.5 Emcure Pharmaceuticals Pvt. Ltd. Related Developments
11.3 Gland Pharma Limited
11.3.1 Gland Pharma Limited Corporation Information
11.3.2 Gland Pharma Limited Description and Business Overview
11.3.3 Gland Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Gland Pharma Limited Peptides Products Offered
11.3.5 Gland Pharma Limited Related Developments
11.4 Troikaa Pharmaceuticals Ltd.
11.4.1 Troikaa Pharmaceuticals Ltd. Corporation Information
11.4.2 Troikaa Pharmaceuticals Ltd. Description and Business Overview
11.4.3 Troikaa Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Troikaa Pharmaceuticals Ltd. Peptides Products Offered
11.4.5 Troikaa Pharmaceuticals Ltd. Related Developments
11.5 Biological E Limited
11.5.1 Biological E Limited Corporation Information
11.5.2 Biological E Limited Description and Business Overview
11.5.3 Biological E Limited Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biological E Limited Peptides Products Offered
11.5.5 Biological E Limited Related Developments
11.6 Bharat Biotech
11.6.1 Bharat Biotech Corporation Information
11.6.2 Bharat Biotech Description and Business Overview
11.6.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bharat Biotech Peptides Products Offered
11.6.5 Bharat Biotech Related Developments
11.7 Samarth Life Sciences Pvt. Ltd.
11.7.1 Samarth Life Sciences Pvt. Ltd. Corporation Information
11.7.2 Samarth Life Sciences Pvt. Ltd. Description and Business Overview
11.7.3 Samarth Life Sciences Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Samarth Life Sciences Pvt. Ltd. Peptides Products Offered
11.7.5 Samarth Life Sciences Pvt. Ltd. Related Developments
11.8 VHB Life Sciences Limited
11.8.1 VHB Life Sciences Limited Corporation Information
11.8.2 VHB Life Sciences Limited Description and Business Overview
11.8.3 VHB Life Sciences Limited Sales, Revenue and Gross Margin (2015-2020)
11.8.4 VHB Life Sciences Limited Peptides Products Offered
11.8.5 VHB Life Sciences Limited Related Developments
11.9 Celon Laboratories Pvt. Ltd.
11.9.1 Celon Laboratories Pvt. Ltd. Corporation Information
11.9.2 Celon Laboratories Pvt. Ltd. Description and Business Overview
11.9.3 Celon Laboratories Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Celon Laboratories Pvt. Ltd. Peptides Products Offered
11.9.5 Celon Laboratories Pvt. Ltd. Related Developments
11.10 United Biotech (P) Limited
11.10.1 United Biotech (P) Limited Corporation Information
11.10.2 United Biotech (P) Limited Description and Business Overview
11.10.3 United Biotech (P) Limited Sales, Revenue and Gross Margin (2015-2020)
11.10.4 United Biotech (P) Limited Peptides Products Offered
11.10.5 United Biotech (P) Limited Related Developments
11.1 Cipla Ltd.
11.1.1 Cipla Ltd. Corporation Information
11.1.2 Cipla Ltd. Description and Business Overview
11.1.3 Cipla Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cipla Ltd. Peptides Products Offered
11.1.5 Cipla Ltd. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Peptides Market Estimates and Projections by Region
12.1.1 Global Peptides Sales Forecast by Regions 2021-2026
12.1.2 Global Peptides Revenue Forecast by Regions 2021-2026
12.2 North America Peptides Market Size Forecast (2021-2026)
12.2.1 North America: Peptides Sales Forecast (2021-2026)
12.2.2 North America: Peptides Revenue Forecast (2021-2026)
12.2.3 North America: Peptides Market Size Forecast by Country (2021-2026)
12.3 Europe Peptides Market Size Forecast (2021-2026)
12.3.1 Europe: Peptides Sales Forecast (2021-2026)
12.3.2 Europe: Peptides Revenue Forecast (2021-2026)
12.3.3 Europe: Peptides Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Peptides Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Peptides Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Peptides Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Peptides Market Size Forecast by Region (2021-2026)
12.5 Latin America Peptides Market Size Forecast (2021-2026)
12.5.1 Latin America: Peptides Sales Forecast (2021-2026)
12.5.2 Latin America: Peptides Revenue Forecast (2021-2026)
12.5.3 Latin America: Peptides Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Peptides Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Peptides Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Peptides Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Peptides Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Peptides Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Peptides Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Peptides Market Segments
Table 2. Ranking of Global Top Peptides Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Peptides Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Insulin
Table 5. Major Manufacturers of Teriparatide
Table 6. Major Manufacturers of Liraglutide
Table 7. Major Manufacturers of Leuprolide
Table 8. Global Peptides Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Peptides Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Peptides Sales by Regions 2015-2020 (K MT)
Table 11. Global Peptides Sales Market Share by Regions (2015-2020)
Table 12. Global Peptides Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Peptides Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Peptides Sales Share by Manufacturers (2015-2020)
Table 15. Global Peptides Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptides as of 2019)
Table 17. Peptides Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Peptides Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Peptides Price (2015-2020) (USD/MT)
Table 20. Peptides Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Peptides Product Type
Table 22. Date of International Manufacturers Enter into Peptides Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptides Sales by Type (2015-2020) (K MT)
Table 25. Global Peptides Sales Share by Type (2015-2020)
Table 26. Global Peptides Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Peptides Revenue Share by Type (2015-2020)
Table 28. Peptides Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Peptides Sales by Application (2015-2020) (K MT)
Table 30. Global Peptides Sales Share by Application (2015-2020)
Table 31. North America Peptides Sales by Country (2015-2020) (K MT)
Table 32. North America Peptides Sales Market Share by Country (2015-2020)
Table 33. North America Peptides Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Peptides Revenue Market Share by Country (2015-2020)
Table 35. North America Peptides Sales by Type (2015-2020) (K MT)
Table 36. North America Peptides Sales Market Share by Type (2015-2020)
Table 37. North America Peptides Sales by Application (2015-2020) (K MT)
Table 38. North America Peptides Sales Market Share by Application (2015-2020)
Table 39. Europe Peptides Sales by Country (2015-2020) (K MT)
Table 40. Europe Peptides Sales Market Share by Country (2015-2020)
Table 41. Europe Peptides Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Peptides Revenue Market Share by Country (2015-2020)
Table 43. Europe Peptides Sales by Type (2015-2020) (K MT)
Table 44. Europe Peptides Sales Market Share by Type (2015-2020)
Table 45. Europe Peptides Sales by Application (2015-2020) (K MT)
Table 46. Europe Peptides Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Peptides Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Peptides Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Peptides Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Peptides Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Peptides Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Peptides Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Peptides Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Peptides Sales Market Share by Application (2015-2020)
Table 55. Latin America Peptides Sales by Country (2015-2020) (K MT)
Table 56. Latin America Peptides Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Peptides Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Peptides Revenue Market Share by Country (2015-2020)
Table 59. Latin America Peptides Sales by Type (2015-2020) (K MT)
Table 60. Latin America Peptides Sales Market Share by Type (2015-2020)
Table 61. Latin America Peptides Sales by Application (2015-2020) (K MT)
Table 62. Latin America Peptides Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Peptides Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Peptides Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Peptides Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Peptides Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Peptides Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Peptides Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Peptides Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Peptides Sales Market Share by Application (2015-2020)
Table 71. Cipla Ltd. Corporation Information
Table 72. Cipla Ltd. Description and Major Businesses
Table 73. Cipla Ltd. Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Cipla Ltd. Product
Table 75. Cipla Ltd. Recent Development
Table 76. Emcure Pharmaceuticals Pvt. Ltd. Corporation Information
Table 77. Emcure Pharmaceuticals Pvt. Ltd. Description and Major Businesses
Table 78. Emcure Pharmaceuticals Pvt. Ltd. Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Emcure Pharmaceuticals Pvt. Ltd. Product
Table 80. Emcure Pharmaceuticals Pvt. Ltd. Recent Development
Table 81. Gland Pharma Limited Corporation Information
Table 82. Gland Pharma Limited Description and Major Businesses
Table 83. Gland Pharma Limited Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Gland Pharma Limited Product
Table 85. Gland Pharma Limited Recent Development
Table 86. Troikaa Pharmaceuticals Ltd. Corporation Information
Table 87. Troikaa Pharmaceuticals Ltd. Description and Major Businesses
Table 88. Troikaa Pharmaceuticals Ltd. Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Troikaa Pharmaceuticals Ltd. Product
Table 90. Troikaa Pharmaceuticals Ltd. Recent Development
Table 91. Biological E Limited Corporation Information
Table 92. Biological E Limited Description and Major Businesses
Table 93. Biological E Limited Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Biological E Limited Product
Table 95. Biological E Limited Recent Development
Table 96. Bharat Biotech Corporation Information
Table 97. Bharat Biotech Description and Major Businesses
Table 98. Bharat Biotech Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Bharat Biotech Product
Table 100. Bharat Biotech Recent Development
Table 101. Samarth Life Sciences Pvt. Ltd. Corporation Information
Table 102. Samarth Life Sciences Pvt. Ltd. Description and Major Businesses
Table 103. Samarth Life Sciences Pvt. Ltd. Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Samarth Life Sciences Pvt. Ltd. Product
Table 105. Samarth Life Sciences Pvt. Ltd. Recent Development
Table 106. VHB Life Sciences Limited Corporation Information
Table 107. VHB Life Sciences Limited Description and Major Businesses
Table 108. VHB Life Sciences Limited Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. VHB Life Sciences Limited Product
Table 110. VHB Life Sciences Limited Recent Development
Table 111. Celon Laboratories Pvt. Ltd. Corporation Information
Table 112. Celon Laboratories Pvt. Ltd. Description and Major Businesses
Table 113. Celon Laboratories Pvt. Ltd. Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Celon Laboratories Pvt. Ltd. Product
Table 115. Celon Laboratories Pvt. Ltd. Recent Development
Table 116. United Biotech (P) Limited Corporation Information
Table 117. United Biotech (P) Limited Description and Major Businesses
Table 118. United Biotech (P) Limited Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. United Biotech (P) Limited Product
Table 120. United Biotech (P) Limited Recent Development
Table 121. Global Peptides Sales Forecast by Regions (2021-2026) (K MT)
Table 122. Global Peptides Sales Market Share Forecast by Regions (2021-2026)
Table 123. Global Peptides Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 124. Global Peptides Revenue Market Share Forecast by Regions (2021-2026)
Table 125. North America: Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 126. North America: Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Europe: Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 128. Europe: Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Asia Pacific: Peptides Sales Forecast by Region (2021-2026) (K MT)
Table 130. Asia Pacific: Peptides Revenue Forecast by Region (2021-2026) (US$ Million)
Table 131. Latin America: Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 132. Latin America: Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Middle East and Africa: Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 134. Middle East and Africa: Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 136. Key Challenges
Table 137. Market Risks
Table 138. Main Points Interviewed from Key Peptides Players
Table 139. Peptides Customers List
Table 140. Peptides Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptides Product Picture
Figure 2. Global Peptides Sales Market Share by Type in 2020 & 2026
Figure 3. Insulin Product Picture
Figure 4. Teriparatide Product Picture
Figure 5. Liraglutide Product Picture
Figure 6. Leuprolide Product Picture
Figure 7. Global Peptides Sales Market Share by Application in 2020 & 2026
Figure 8. Diabetes
Figure 9. Infectious Diseases
Figure 10. Cancer
Figure 11. Osteoporosis
Figure 12. Peptides Report Years Considered
Figure 13. Global Peptides Market Size 2015-2026 (US$ Million)
Figure 14. Global Peptides Sales 2015-2026 (K MT)
Figure 15. Global Peptides Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Peptides Sales Market Share by Region (2015-2020)
Figure 17. Global Peptides Sales Market Share by Region in 2019
Figure 18. Global Peptides Revenue Market Share by Region (2015-2020)
Figure 19. Global Peptides Revenue Market Share by Region in 2019
Figure 20. Global Peptides Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Peptides Revenue in 2019
Figure 22. Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Peptides Sales Market Share by Type (2015-2020)
Figure 24. Global Peptides Sales Market Share by Type in 2019
Figure 25. Global Peptides Revenue Market Share by Type (2015-2020)
Figure 26. Global Peptides Revenue Market Share by Type in 2019
Figure 27. Global Peptides Market Share by Price Range (2015-2020)
Figure 28. Global Peptides Sales Market Share by Application (2015-2020)
Figure 29. Global Peptides Sales Market Share by Application in 2019
Figure 30. Global Peptides Revenue Market Share by Application (2015-2020)
Figure 31. Global Peptides Revenue Market Share by Application in 2019
Figure 32. North America Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Peptides Sales Market Share by Country in 2019
Figure 35. North America Peptides Revenue Market Share by Country in 2019
Figure 36. U.S. Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Peptides Market Share by Type in 2019
Figure 41. North America Peptides Market Share by Application in 2019
Figure 42. Europe Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Peptides Sales Market Share by Country in 2019
Figure 45. Europe Peptides Revenue Market Share by Country in 2019
Figure 46. Germany Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Peptides Market Share by Type in 2019
Figure 57. Europe Peptides Market Share by Application in 2019
Figure 58. Asia Pacific Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Peptides Sales Market Share by Region in 2019
Figure 61. Asia Pacific Peptides Revenue Market Share by Region in 2019
Figure 62. China Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Peptides Market Share by Type in 2019
Figure 85. Asia Pacific Peptides Market Share by Application in 2019
Figure 86. Latin America Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Peptides Sales Market Share by Country in 2019
Figure 89. Latin America Peptides Revenue Market Share by Country in 2019
Figure 90. Mexico Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Peptides Market Share by Type in 2019
Figure 97. Latin America Peptides Market Share by Application in 2019
Figure 98. Middle East and Africa Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Peptides Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Peptides Revenue Market Share by Country in 2019
Figure 102. Turkey Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Peptides Market Share by Type in 2019
Figure 109. Middle East and Africa Peptides Market Share by Application in 2019
Figure 110. North America Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
組換えペプチドの世界市場（～2026年） Market Analysis and Insights: Global Recombinant Peptides Market The global Recombinant Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Recombinant Peptides Scope and Market Size Recombinant Peptides market is…- 経口タンパク質・ペプチドの世界市場（～2026年） Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs. The oral protein and peptide-based therapeutics market for diabetes is expected to gro…
- 抗炎症ペプチドの世界市場（～2026年） Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal's skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and…
- バイオアクティブプロテイン・ペプチドの世界市場（～2026年） Bio Active Protein and Peptides are peptide compounds that have beneficial or physiological effects on the life activities of living organisms. They are a class of peptides with a relative molecular mass of less than 6000 Da and various biological functions. Bioactive peptides have a variety of huma…
- 抗菌ペプチドの世界市場（～2026年） Antimicrobial peptides (AMPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate …